Suspected Hydroxychloroquine-Associated QT-Interval Prolongation in a Patient With Systemic Lupus Erythematosus
- 1 August 2013
- journal article
- case report
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 19 (5), 286-288
- https://doi.org/10.1097/rhu.0b013e31829d5e50
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Fatal Antimalarial-Induced CardiomyopathyJCR: Journal of Clinical Rheumatology, 2012
- The role of antimalarial agents in the treatment of SLE and lupus nephritisNature Reviews Nephrology, 2011
- Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosusArthritis Care & Research, 2010
- QT interval prolongation and torsade de pointesInternational Journal of Cardiology, 2009
- QT Interval: How to Measure It and What Is “Normal”Journal of Cardiovascular Electrophysiology, 2006
- Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literatureSeminars in Arthritis and Rheumatism, 2004
- Long QT syndrome: Diagnosis and managementAmerican Heart Journal, 2002
- Treatment of systemic lupus erythematosusInternational Immunopharmacology, 2001
- Will some day PAPS fade into SLE?Lupus, 1996
- TREATMENT OF LUPUS ERYTHEMATOSUS WITH MEPACRINEThe Lancet, 1951